Therefore, the combination of CXCR4 expression in both tumor cells and TILs was not associated with the survival of ESCC patients in this study (data not shown), and other studies on CXCR4 expression in tumor tissues and the clinical outcomes of ESCC patients also have reported conflicting results [50,51]. The gene discussed is CXCR4; the disease is neoplasm.